Potent monoclonal antibodies against Clostridium difficile toxin A elicited by DNA immunization

References

• Liu MA. DNA vaccines: an historical perspective and view to the future. Immunol Rev 2011; 239:62 - 84; http://dx.doi.org/10.1111/j.1600-065X.2010.00980.x; PMID: 21198665
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Weiner DB. DNA vaccines: ready for prime time?. Nat Rev Genet 2008; 9:776 - 88; http://dx.doi.org/10.1038/nrg2432; PMID: 18781156
   PubMed Web of Science ®Google Scholar
• Wang S, Parker C, Taaffe J, Solórzano A, García-Sastre A, Lu S. Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. Vaccine 2008; 26:3626 - 33; http://dx.doi.org/10.1016/j.vaccine.2008.04.073; PMID: 18538900
   PubMed Web of Science ®Google Scholar
• Ledgerwood JE, Wei CJ, Hu Z, Gordon IJ, Enama ME, Hendel CS, et al, VRC 306 Study Team. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. Lancet Infect Dis 2011; 11:916 - 24; http://dx.doi.org/10.1016/S1473-3099(11)70240-7; PMID: 21975270
   PubMed Web of Science ®Google Scholar
• Harari A, Bart PA, Stöhr W, Tapia G, Garcia M, Medjitna-Rais E, et al. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J Exp Med 2008; 205:63 - 77; http://dx.doi.org/10.1084/jem.20071331; PMID: 18195071
   PubMed Web of Science ®Google Scholar
• Yan J, Corbitt N, Pankhong P, Shin T, Khan A, Sardesai NY, et al. Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine. Vaccine 2011; 29:7173 - 81; http://dx.doi.org/10.1016/j.vaccine.2011.05.076; PMID: 21651948
   PubMed Web of Science ®Google Scholar
• Pillet S, Kobasa D, Meunier I, Gray M, Laddy D, Weiner DB, et al. Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets. Vaccine 2011; 29:6793 - 801; http://dx.doi.org/10.1016/j.vaccine.2010.12.059; PMID: 21211587
   PubMed Web of Science ®Google Scholar
• Vaine M, Wang S, Crooks ET, Jiang P, Montefiori DC, Binley J, et al. Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccination. J Virol 2008; 82:7369 - 78; http://dx.doi.org/10.1128/JVI.00562-08; PMID: 18495775
   PubMed Web of Science ®Google Scholar
• Vaine M, Wang S, Hackett A, Arthos J, Lu S. Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity. Vaccine 2010; 28:2999 - 3007; http://dx.doi.org/10.1016/j.vaccine.2010.02.006; PMID: 20170767
   PubMed Web of Science ®Google Scholar
• Wang S, Chou TH, Sakhatskyy PV, Huang S, Lawrence JM, Cao H, et al. Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system. J Virol 2005; 79:1906 - 10; http://dx.doi.org/10.1128/JVI.79.3.1906-1910.2005; PMID: 15650214
   PubMed Web of Science ®Google Scholar
• Wang S, Taaffe J, Parker C, Solórzano A, Cao H, García-Sastre A, et al. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines. J Virol 2006; 80:11628 - 37; http://dx.doi.org/10.1128/JVI.01065-06; PMID: 16987975
   PubMed Web of Science ®Google Scholar
• Barry MA, Barry ME, Johnston SA. Production of monoclonal antibodies by genetic immunization. Biotechniques 1994; 16:616 - 8, 620; PMID: 8024780
   PubMed Web of Science ®Google Scholar
• Al-Qaoud KM, Al-Omari MM, Al-Aghbar M, Abdel-Hafez SK. Production of monoclonal antibodies against the 8 kDa subunit of Echinococcus granulosus Antigen B (EgAgB8/2) using DNA immunization. Hybridoma (Larchmt) 2008; 27:431 - 8; http://dx.doi.org/10.1089/hyb.2008.0039; PMID: 18803505
   PubMed Web of Science ®Google Scholar
• Martín-Folgar R, Lorenzo G, Boshra H, Iglesias J, Mateos F, Borrego B, et al. Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization. MAbs 2010; 2:275 - 84; http://dx.doi.org/10.4161/mabs.2.3.11676; PMID: 20400862
   PubMed Web of Science ®Google Scholar
• Jin K, Wang S, Zhang C, Xiao Y, Lu S, Huang Z. Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B. Hum Vaccin Immunother 2013; 9:63 - 73; http://dx.doi.org/10.4161/hv.22434; PMID: 23143772
   PubMed Web of Science ®Google Scholar
• Jin K, Wang S, Huang Z, Lu S. Clostridium difficile infections in China. J Biomed Res 2010; 24:411 - 6; http://dx.doi.org/10.1016/S1674-8301(10)60055-3; PMID: 23554657
   PubMedGoogle Scholar
• Wei J, Yan B, Chen Z, Li T, Deng F, Wang H, et al. Production and characterization of monoclonal antibodies against the hemagglutinin of H5N1 and antigenic investigation of avian influenza H5N1 viruses isolated from China. Can J Microbiol 2011; 57:42 - 8; http://dx.doi.org/10.1139/W10-097; PMID: 21217796
   PubMed Web of Science ®Google Scholar
• Tan GS, Krammer F, Eggink D, Kongchanagul A, Moran TM, Palese P. A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J Virol 2012; 86:6179 - 88; http://dx.doi.org/10.1128/JVI.00469-12; PMID: 22491456
   PubMed Web of Science ®Google Scholar
• Ulivieri C, Burroni D, Telford JL, Baldari CT. Generation of a monoclonal antibody to a defined portion of the Helicobacter pylori vacuolating cytotoxin by DNA immunization. J Biotechnol 1996; 51:191 - 4; http://dx.doi.org/10.1016/0168-1656(96)01610-0; PMID: 8987885
   PubMed Web of Science ®Google Scholar
• Puttikhunt C, Kasinrerk W, Srisa-ad S, Duangchinda T, Silakate W, Moonsom S, et al. Production of anti-dengue NS1 monoclonal antibodies by DNA immunization. J Virol Methods 2003; 109:55 - 61; http://dx.doi.org/10.1016/S0166-0934(03)00045-4; PMID: 12668268
   PubMed Web of Science ®Google Scholar
• Horimoto T, Fukuda N, Iwatsuki-Horimoto K, Guan Y, Lim W, Peiris M, et al. Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003. J Vet Med Sci 2004; 66:303 - 5; http://dx.doi.org/10.1292/jvms.66.303; PMID: 15107562
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang C, Zhang L, Li J, Huang Z, Lu S. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Vaccine 2008; 26:2100 - 10; http://dx.doi.org/10.1016/j.vaccine.2008.02.033; PMID: 18378365
   PubMed Web of Science ®Google Scholar
• Jin K, Wang S, Huang Z, Lu S. Clostridium difficile infections in China. J Biomed Res 2010; 24:411 - 6; http://dx.doi.org/10.1016/S1674-8301(10)60055-3; PMID: 23554657
   PubMedGoogle Scholar
• Ryder AB, Huang Y, Li H, Zheng M, Wang X, Stratton CW, et al. Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system. J Clin Microbiol 2010; 48:4129 - 34; http://dx.doi.org/10.1128/JCM.01104-10; PMID: 20720023
   PubMed Web of Science ®Google Scholar
• Smith K, Garman L, Wrammert J, Zheng NY, Capra JD, Ahmed R, et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc 2009; 4:372 - 84; http://dx.doi.org/10.1038/nprot.2009.3; PMID: 19247287
   PubMed Web of Science ®Google Scholar
• Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008; 453:667 - 71; http://dx.doi.org/10.1038/nature06890; PMID: 18449194
   PubMed Web of Science ®Google Scholar
• Liao HX, Levesque MC, Nagel A, Dixon A, Zhang R, Walter E, et al. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J Virol Methods 2009; 158:171 - 9; http://dx.doi.org/10.1016/j.jviromet.2009.02.014; PMID: 19428587
   PubMed Web of Science ®Google Scholar
• Lightwood DJ, Carrington B, Henry AJ, McKnight AJ, Crook K, Cromie K, et al. Antibody generation through B cell panning on antigen followed by in situ culture and direct RT-PCR on cells harvested en masse from antigen-positive wells. J Immunol Methods 2006; 316:133 - 43; http://dx.doi.org/10.1016/j.jim.2006.08.010; PMID: 17027850
   PubMed Web of Science ®Google Scholar
• Cline J, Braman JC, Hogrefe HH. PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. Nucleic Acids Res 1996; 24:3546 - 51; http://dx.doi.org/10.1093/nar/24.18.3546; PMID: 8836181
   PubMed Web of Science ®Google Scholar